02:34The unknown eye condition linked to skinny jabs
From the creator
People with a rare eye condition that causes ‘frightening’ vision loss have told ITV News they believe it was caused by weight-loss medication, prompting experts to advise people to get their eyes checked before taking the drugs. It comes as the UK medicines health regulator last month issued a safety warning after receiving three reports linking Semaglutide - known by brand names Ozempic, Wegovy and Rybelsus - to the incurable eye condition called NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy). In response to this ITV News investigation, Novo Nordisk said: "Patient safety is our top priority, and we take any reports about adverse events from the use of our medicines very seriously. We work closely with authorities and regulatory bodies from around the world to continuously monitor the safety profile of our products. "The EU SmPC and patient leaflets for Wegovy, Ozempic, (Semaglutide injection) and Rybelsus have been updated to include "Non-arteritic anterior ischemic optic neuropathy (NAION)" and under section 4.4 “Special warnings and precautions for use” and as an adverse drug reaction in section 4.8 "Undesirable effects" (frequency: very rare, meaning it may effect up to 1 in 10,000 people taking Semaglutide). "Based on the totality of evidence we concluded that the data did not suggest a reasonable possibility of a causal relationship between Semaglutide and NAION and Novo Nordisk believes that the benefit-risk profile of Semaglutide remains favourable.
Published 2026-03-11 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





